Epidemiology of estrogen and dementia in women with Down syndrome

Nicole Schupf, Joseph H. Lee, Deborah Pang, Warren B. Zigman, Benjamin Tycko, Sharon Krinsky-McHale, Wayne Silverman

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Several lines of investigation have shown a protective role for estrogen in Alzheimer's disease through a number of biological actions. This review examines studies of the role of estrogen-related factors in age at onset and risk for Alzheimer's disease in women with Down syndrome, a population at high risk for early onset of dementia. The studies are consistent in showing that early age at menopause and that low levels of endogenous bioavailable estradiol in postmenopausal women with Down syndrome are associated with earlier age at onset and overall risk for dementia. Polymorphisms in genes associated with estrogen receptor activity and in genes for estrogen biosynthesis affecting endogenous estrogen are related to age at onset and cumulative incidence of dementia, and may serve as biomarkers of risk. To date, no clinical trials of estrogen or hormone replacement therapy (ERT/HRT) have been published for women with Down syndrome. While findings from clinical trials of ERT or HRT for dementia have generally been negative among women in the neurotypical population, the short interval between menopause and onset of cognitive decline, together with a more positive balance between potential benefits and risks, suggests an opportunity to evaluate the efficacy of ERT/HRT for delaying or preventing dementia in this high risk population, although questions concerning the optimal formulation and timing of the hormone therapy are not yet resolved.

Original languageEnglish (US)
Pages (from-to)62-68
Number of pages7
JournalFree Radical Biology and Medicine
StatePublished - Jan 2018


  • Dementia
  • Down syndrome
  • Epidemiology
  • Estrogen
  • Polymorphisms

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)


Dive into the research topics of 'Epidemiology of estrogen and dementia in women with Down syndrome'. Together they form a unique fingerprint.

Cite this